Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 16Zidovudine 13Vincristine 12Bleomycin 11Interferon alpha-2 6Cyclophosphamide 6Methotrexate 5Liposomes 5Leucovorin 5Dexamethasone 5tecogalan 4sargramostim 4Filgrastim 4Etoposide 4Cytarabine 4Ritonavir 3Nivolumab 3Fluorouracil 3pomalidomide 2liposomal doxorubicin 2interferon alfa-n1 2Watchful Waiting 2Valganciclovir 2Tumor Necrosis Factor-alpha 2Tobacco Use Cessation Devices 2Thalidomide 2Surveys and Questionnaires 2Rituximab 2Paclitaxel 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Acquired Immunodeficiency Syndrome × Interleukin-4 × Clear all
NCT00000769 2021-10-28

A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
48 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡